We are live on
!
Find out more
BA
BlackRock Advisors Portfolio holdings
AUM
$98.8B
1-Year Est. Return
15.8%
This Fund
S&P 500
This Quarter
Est. Return
+1.95%
1 Year Est. Return
+15.8%
3 Year Est. Return
+32.35%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$97.6B
AUM Growth
-$1.7B
(-1.7%)
Cap. Flow
-$3.16B
Cap. Flow
% of AUM
-3.24%
Top 10 Holdings %
Top 10 Hldgs %
14.39%
Holding
3,772
New
78
Increased
2,174
Reduced
812
Closed
154
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$461M |
| 2 |
Elevance Health
ELV
|
+$290M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$241M |
| 4 |
MBLY
Mobileye N.V.
MBLY
|
+$234M |
| 5 |
Microsoft
MSFT
|
+$171M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$382M |
| 2 |
HSP
HOSPIRA INC
HSP
|
+$235M |
| 3 |
Merck
MRK
|
+$227M |
| 4 |
AGN
Allergan Inc
AGN
|
+$199M |
| 5 |
American Express
AXP
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.47% |
| 2 | Financials | 16.8% |
| 3 | Industrials | 9.81% |
| 4 | Technology | 8.84% |
| 5 | Energy | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PCYC
1151
DELISTED
PHARMACYCLICS INC
PCYC
| $2.3M | ﹤0.01% |
8,998
| – | – |
|
1152
Textron
TXT
$15.6B
| $2.3M | ﹤0.01% |
51,921
-68
| -0.1% | -$2.96K |
|
1153
Ascendis Pharma A/S
ASND
$16.7B
| $2.28M | ﹤0.01% |
+131,300
| New | +$2.39M |
|
1154
SPX Corp
SPXC
$10.2B
| $2.28M | ﹤0.01% |
106,439
-363,743
| -77% | -$7.81M |
|
1155
Westwood Holdings Group
WHG
$187M
| $2.28M | ﹤0.01% |
37,741
+6,386
| +20% | +$388K |
|
1156
Dana Inc
DAN
$2.95B
| $2.27M | ﹤0.01% |
107,512
+18,983
| +21% | +$410K |
|
1157
iShares Russell 1000 ETF
IWB
$47.9B
| $2.27M | ﹤0.01% |
19,614
+2,895
| +17% | +$334K |
|
1158
Lincoln Educational Services
LINC
$1.33B
| $2.27M | ﹤0.01% |
994,766
-12,635
| -1% | -$33.2K |
|
|
ZAGG
1159
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
| $2.26M | ﹤0.01% |
261,139
| – | – |
|
1160
Wolverine World Wide
WWW
$1.71B
| $2.26M | ﹤0.01% |
67,618
+13,186
| +24% | +$390K |
|
|
SCLN
1161
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
| $2.26M | ﹤0.01% |
254,884
+10,974
| +4% | +$87.4K |
|
1162
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.33B
| $2.25M | ﹤0.01% |
31,456
+8,731
| +38% | +$618K |
|
1163
Glacier Bancorp
GBCI
$6.45B
| $2.25M | ﹤0.01% |
89,671
+7,216
| +9% | +$179K |
|
|
SF
1164
Stifel
SF
$12.8B
| $2.25M | ﹤0.01% |
90,934
+13,579
| +18% | +$314K |
|
1165
Varonis Systems
VRNS
$5.13B
| $2.25M | ﹤0.01% |
263,433
+11,823
| +5% | +$126K |
|
1166
Guidewire Software
GWRE
$13.3B
| $2.25M | ﹤0.01% |
42,700
+5,998
| +16% | +$311K |
|
|
CLCT
1167
DELISTED
Collectors Universe
CLCT
| $2.23M | ﹤0.01% |
98,845
+3,489
| +4% | +$78.4K |
|
1168
Sinclair Inc
SBGI
$1.02B
| $2.23M | ﹤0.01% |
70,973
-2,634,811
| -97% | -$71.6M |
|
1169
Trane Technologies
TT
$104B
| $2.23M | ﹤0.01% |
32,713
-3,185
| -9% | -$210K |
|
1170
Curtiss-Wright
CW
$26.9B
| $2.22M | ﹤0.01% |
30,010
+4,441
| +17% | +$311K |
|
|
CBPO
1171
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $2.22M | ﹤0.01% |
23,232
-6,090
| -21% | -$456K |
|
|
PLCM
1172
DELISTED
POLYCOM INC
PLCM
| $2.22M | ﹤0.01% |
165,391
+12,801
| +8% | +$171K |
|
|
ZEN
1173
DELISTED
ZENDESK INC
ZEN
| $2.21M | ﹤0.01% |
97,547
+1,550
| +2% | +$37.1K |
|
1174
American Eagle Outfitters
AEO
$3.04B
| $2.21M | ﹤0.01% |
129,364
+28,594
| +28% | +$436K |
|
|
EQY
1175
DELISTED
Equity One
EQY
| $2.2M | ﹤0.01% |
82,509
+20,027
| +32% | +$539K |
|
Similar funds
BIM
BJ
IC
EAM
MFS
CIM
KAM
PFM
BlackRock Advisors's Q1 2015 Portfolio in Review
As of Q1 2015, BlackRock Advisors held 3,772 positions worth $97.6B, down 1.7% from $99.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
BlackRock Advisors withdrew a net $3.16B in Q1 2015, closing 154 positions and reducing 812 holdings. Its most notable exit was Allergan Inc, an estimated $199M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 17% a quarter earlier, followed by Financials and Industrials.
Against the trend, BlackRock Advisors opened a new position in Mobileye N.V. worth $252M.
- BlackRock Advisors's largest Q1 2015 buy was Mobileye N.V.: 6,000,666 shares worth $252M.
- BlackRock Advisors added most to UnitedHealth in Q1 2015, an estimated $461M increase.
- BlackRock Advisors's biggest Q1 2015 reduction was Chevron, cutting an estimated $382M.
- BlackRock Advisors fully exited Allergan Inc in Q1 2015, selling an estimated $199M.
- BlackRock Advisors's ten largest holdings make up 14% of its $97.6B portfolio in Q1 2015.
- BlackRock Advisors opened 78 new positions and closed 154 in Q1 2015.
- BlackRock Advisors's portfolio value fell 1.7% quarter-over-quarter to $97.6B.
Based on BlackRock Advisors's 13F filing for Q1 2015, filed 13 May 2015.